(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 8.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Rxsight's revenue in 2025 is $148,310,000.On average, 5 Wall Street analysts forecast RXST's revenue for 2025 to be $5,649,434,373, with the lowest RXST revenue forecast at $5,087,750,021, and the highest RXST revenue forecast at $7,701,114,269. On average, 6 Wall Street analysts forecast RXST's revenue for 2026 to be $6,567,952,054, with the lowest RXST revenue forecast at $4,986,157,569, and the highest RXST revenue forecast at $9,785,385,025.
In 2027, RXST is forecast to generate $7,751,179,030 in revenue, with the lowest revenue forecast at $5,445,355,454 and the highest revenue forecast at $11,813,983,116.